Skip to main content
Top

Current Treatment Options in Oncology

Issue 5/2017

Content (7 Articles)

Head and Neck Cancer (L Licitra, Section Editor)

Quality of Life Measurements: Any Value for Clinical Practice?

Matthias Büttner, Veit Zebralla, Andreas Dietz, Susanne Singer

Head and Neck Cancer (L Licitra, Section Editor)

The Latest Advancements in Selective Neck Dissection for Early Stage Oral Squamous Cell Carcinoma

Zong-shan Shen, Jin-song Li, Wei-liang Chen, Song Fan

Head and Neck Cancer (L Licitra, Section Editor)

Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?

Luca Tonella, Marco Giannoccaro, Salvatore Alfieri, Silvana Canevari, Loris De Cecco

Sarcoma (SH Okuno, Section Editor)

Desmoid-Type Fibromatosis: Who, When, and How to Treat

Javier Martínez Trufero, Isabel Pajares Bernad, Irene Torres Ramón, Jorge Hernando Cubero, Roberto Pazo Cid

Breast Cancer (ML Telli, Section Editor)

Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women

Lorenzo Rossi, Olivia Pagani

Breast Cancer (ML Telli, Section Editor)

The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition

Anosheh Afghahi, Allison W. Kurian

Genitourinary Cancers (W Oh and M Galsky, Section Editors)

Management Options for Biochemically Recurrent Prostate Cancer

Farhad Fakhrejahani, Ravi A. Madan, William L. Dahut

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine